LadanZandMD

Nephrology • Rochester, MN

Glomerular Disease

Associate Professor, Internal Medicine, Mayo Clinic

Join to view full profile

Dr. Zand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Zand's full profile

Already have an account?

Office
200 First St SW
Rochester, MN 55905
Phone+1 507-284-2511
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 2011 - 2014
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2008 - 2011
University of Toronto Faculty of MedicineClass of 2008

Certifications & Licensure

ND State Medical License 2022 - 2026
IA State Medical License 2022 - 2026
IL State Medical License 2023 - 2026
WI State Medical License 2021 - 2025
MI State Medical License 2022 - 2025
MN State Medical License 2009 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) Start of enrollment: 2018 Jun 01
Withdrawn
Phase 2

Publications & Presentations

PubMed

2 citations
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.
Sean J Barbour, Rosanna Coppo, Lee Er, Evangeline Pillebout, Maria Luisa Russo, Charles E Alpers, Agnes B Fogo, Franco Ferrario, J Charles Jennette, Ian S D Roberts, H...> ;Clinical Journal of the American Society of Nephrology. 2024 Apr 1
1 citations
Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy.
Vaughan, L., Miao, J., Duriseti, P., Radhakrishnan, Y., Fervenza, F., Zand, L.> ;Kidney International Reports. 2024 Jan 1
2 citations
Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients.
Coppo, R., Zand, L., Fervenza, F.> ;Clinical Kidney Journal. 2023 Dec 1
1 citations
Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD.
Janina Paula T Sy-Go, Simon Moubarak, Lisa E Vaughan, Nattawat Klomjit, Jason K Viehman, Ladan Zand, F C Fervenza> ;Clinical Journal of the American Society of Nephrology. 2024 Mar 1
2 citations
Membranous nephropathy treatment standard.
Yeshwanter Radhakrishnan, Ladan Zand, Sanjeev Sethi, Fernando C Fervenza> ;Nephrology, Dialysis, Transplantation. 2024 Feb 28
3 citations
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification.
Sanjeev Sethi, Laurence H Beck Jr, Richard J Glassock, Mark Haas, An S De Vriese, Tiffany N Caza, Elion Hoxha, Gérard Lambeau, Nicola M Tomas, Benjamin Madden, Hanna D...> ;Mayo Clinic Proceedings. 2023 Nov 1
7 citations
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Sanjeev Sethi, Laurence H Beck Jr, Richard J Glassock, Mark Haas, An S De Vriese, Tiffany N Caza, Elion Hoxha, Gérard Lambeau, Nicola M Tomas, Benjamin Madden, Hanna D...> ;Kidney International. 2023 Dec 1
1 citations
Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy.
Ladan Zand, Fernando C Fervenza> ;Clinical Kidney Journal. 2023 Sep 1
1 citations
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Sean J Barbour, Fernando C Fervenza, Dilshani Induruwage, Paul E Brenchley, Brad Rovin, Michelle A Hladunewich, Heather N Reich, Richard Lafayette, Nabeel Aslam, Geral...> ;Clinical Journal of the American Society of Nephrology. 2023 Oct 1
7 citations
COVID-19 and Glomerular Diseases.
Nattawat Klomjit, Ladan Zand, Lynn D Cornell, Mariam Priya Alexander> ;Kidney International Reports. 2023 Jun 1
3 citations
PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations.
Marta Casal Moura, Cynthia S Crowson, Ulrich Specks, Kenneth J Warrington, Ladan Zand, Sanjeev Sethi, Fernando C Fervenza> ;Clinical Kidney Journal. 2023 Mar 1
Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report.
Simon Moubarak, Loren P Herrera Hernandez, Lynn D Cornell, Tiffany Caza, Ladan Zand> ;Kidney Medicine. 2023 Jan 1
3 citations
Maintenance of Remission and Risk of Relapse in Myeloperoxidase-Positive ANCA-Associated Vasculitis with Kidney Involvement.
Marta Casal Moura, Ulrich Specks, Sanjeev Sethi, Dalia Zubidat, Luca Nardelli, Fernanda G Dos Santos, Ciria Sousa, Juan León-Róman, Shane A Bobart, Eddie Greene, Ladan...> ;Clinical Journal of the American Society of Nephrology. 2023 Jan 1
7 citations
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades Using the Lupus Midwest Network.
Mehmet Hocaoǧlu, Maria O Valenzuela-Almada, Jesse Y Dabit, Shirley-Ann Osei-Onomah, Baptiste Chevet, Rachel E Giblon, Ladan Zand, Fernando C Fervenza, Charles G Helmic...> ;Arthritis & Rheumatology. 2023 Apr 1
1 citations
A Pregnant Woman With New-Onset Hypertension and Acute Kidney Injury.
Jing Miao, Samih H Nasr, Ladan Zand, Andrea G Kattah> ;Kidney International Reports. 2022 Apr 1
Catastrophic kidney infarction.
Nattawat Klomjit, Ladan Zand> ;Kidney International. 2022 Jan 1
4 citations
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY.
Nattawat Klomjit, Ladan Zand> ;Kidney360. 2021 Nov 25
27 citations
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
Ladan Zand, S. Vincent Rajkumar, Nelson Leung, Sanjeev Sethi, Mireille El Ters, Fernando C. Fervenza> ;Journal of the American Society of Nephrology. 2021 Mar 8
5 citations
Validation of prognostic indices for short term mortality in an incident dialysis population of older adults >75
Bjorg Thorsteinsdottir, La Tonya J. Hickson, Rachel Giblon, Atieh Pajouhi, Natalie Connell, Megan E. Branda, Amrit K. Vasdev, Rozalina G. McCoy, Ladan Zand, Navdeep Ta...> ;Plos One. 2021 Jan 20
1 citations
CYP24A1 deficiency causing persistent hypercalciuria in a stone former
Janina Paula T. Sy-Go, Ladan Zand, Peter C. Harris, John C. Lieske> ;Journal of Nephrology. 2021 Jan 2
10 citations
Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study.
Stephen B. Erickson, Ladan Zand, Samih H. Nasr, Mariam P. Alexander, Nelson Leung, Maria Eleni Drosou, Fernando C. Fervenza> ;Nephrology, Dialysis, Transplantation. 2021 Jan 1
12 citations
Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series
Mireille El Ters, Shane A. Bobart, Lynn D. Cornell, Nelson Leung, Andrew Bentall, Sanjeev Sethi, Mary E. Fidler, Joseph P. Grande, Loren P. Herrera Hernandez, Fernando...> ;American Journal of Kidney Diseases. 2020 Oct 1
27 citations
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, St...> ;Autoimmunity Reviews. 2020 Sep 15
3 citations
Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease.
Cihan Heybeli, Stephen B. Erickson, Fernando C. Fervenza, Marie C. Hogan, Ladan Zand, Nelson Leung> ;Nephrology, Dialysis, Transplantation. 2021 Sep 27
18 citations
Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 Cases.
Sandra M. Herrmann, Mariam P. Alexander, Michael F. Romero, Ladan Zand> ;Kidney Medicine. 2020 Sep 1
Join now to see all